Company / Financials
Enveric Biosciences, Inc. Financials
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$43.0M
FY2019 · -11.5% YoY
Net Income
-$16.9M
FY2019 · -86.2% YoY
Profit Margin
-39.3%
FY2019 · net income / revenue
ROE
-86.9%
FY2019 · return on equity
Total Assets
$29.6M
FY2019
Total Debt
-
FY2019
Equity
$19.4M
FY2019
ROA
-57.0%
FY2019 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$43.0M-11.5% YoYNet Income HistoryProfit after all expenses and taxes-$16.9M-86.2% YoYGross Profit HistoryRevenue minus cost of goods sold$9.0M-12.3% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$34.0M-11.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$7.1M+34.4% YoYSG&A Expense HistorySelling, general, and administrative expenses$10.8M-41.7% YoYInterest Expense HistoryCost of borrowing and debt obligations$729.9K+26.9% YoYIncome Tax HistoryTotal income tax expense$6.3M+365.4% YoYEPS (Basic) HistoryBasic earnings per share-$20.47-2629.3% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$20.47-2629.3% YoY